• Journal of Photoscience
• /
• 제9권2호
• /
• pp.106-109
• /
• 2002

Archaeal rhodopsins possess retinal molecule as their chromophores, and their light-energy and light-signal conversions are triggered by all-trans to 13-cis isomerization of the retinal chromophore. Relaxation through structural changes of protein then leads to functional processes, proton pump in bacteriorhodopsin (bR) and transducer activation in phoborhodopsin (pR). It is known that sensory rhodopsins can pump protons in the absence of their transducers. Thus, there should be common and specific features in their protein structural changes for function. In this paper, our r ecent studies on pR from Natronobacterium pharaonis (ppR) by means of low-temperature Fourier-transform infrared (FTIR) spectroscopy are compared with those of bR. In particular, protein structural changes upon retinal photoisomerization are studied. Comparative investigation of ppR and bR revealed the similar structures of the polyene chain of the chromophore and water-containing hydrogen-bonding network, whereas the structural changes upon photoisomerization were more extended in ppR than in bR. Extended protein structural changes were clearly shown by the assignment of the C=O stretch of Asnl05. FTIR studies of a ppR mutant with the same retinal binding site as in bR revealed that the Schiff base region is important to determine their colors.

• Applied Microscopy
• /
• 제22권2호
• /
• pp.84-96
• /
• 1992

Turtle bladder 상피세포(上皮細胞)의 수송기작(輸送機作)을 in vitro에서 효과적으로 연구하기 위하여 Lucite chamber 한가운데 상피조직을 두고 전압고정법(電壓固定法)을 적용하여 상피 세포층의 막전위(膜電位)를 측정한 후 급속 동결(凍結)하고 투과 및 주사형 전자현미경(電子顯微鏡)으로 탄산 탈수효소를 함유하는 세포의 표면막 특성을 분석(分析)하였다. 방광(膀胱)의 점막층(粘膜層)은 두 타입의 탄산탈수효소를 함유한 세포가 특징적인데 정단부(丁端部)와 기저부(基底部) 세포막에서는 각기 다른 수송의 특성을 나타내고 있다. 즉 ${\alpha}$ 및 ${\beta}$형 탄산탈수효소가 풍부한 세포는 정단세포막(丁端細胞膜)의 proton 펌프를 이용하여 $H^+$ 분필(分泌)에 관여하거나 bicarbonate의 재흡수(再吸收) 기능을 가지는 것으로 믿어진다. 본 연구에서 탄산탈수효소를 함유한 ${\alpha}$형의 세포의 proton 분필수송(分泌輸送)과 세포막 투과성 변화와의 상관관계를 관찰하였는 바, 이들 세포에서 $H^+$을 분비하는 과정에서 정단부의 표면세포막(表面細胞膜) P-face에는 특이한 구조로서 세포막내(細胞膜內) 입자(粒子)들이 다량으로 분포하였다. 이와같은 세포막내(細胞膜內) 입자(粒子)들은 proton 펌프를 함유하는 것으로 생각되며 ${\beta}$형의 세포에서는 기저세포막(基底細胞膜)에서 관찰되고 있다. 이와같은 결과는 방광상피(膀胱上皮) 세포내 탄산탈수효소는 $H^+$과 $HCO_{3}^{-}$의 생성에 관여하지만, 특히 ${\alpha}$형 세포에서 정단세포막의 proton 펌프를 이용한 $H^{+}$ 분필수송(分泌輸送)과 기저세포막을 통한 bicarbonate의 재흡수(再吸收) 기능을 설명해 주는 중요한 사실로서 사료된다.

• Applied Microscopy
• /
• 제19권2호
• /
• pp.119-137
• /
• 1989

Turtle bladder의 상피조직(上皮組織)과 세포막(細胞膜) 투과성(透過性)을 분석하기 위하여 동결절단법(凍結切斷法)을 적용(適用)하여 전자현미경(電子顯微鏡) 관찰을 하였으며 그 결과 다음과 같이 요약(要約)된다. 1. 방광상피(膀胱上皮)의 3가지 주요세포형(主要細胞形)은 granular-cell, ${\alpha}$ 및 ${\beta}$형(形)의 CA-rich cell로서 구분된다. 2. 과립성세포(顆粒性細胞)의 주요기능(主要機能)은 $Na^+$ 재흡수(再吸收)이며, 두 단계(段階)의 수송과정(輸送過程)으로 설명되며 정단세포막(頂端細胞膜)을 통한 $Na^+$의 세포내(細胞內) 확산이동(擴散移動)과 그후 기저막(基底膜)에 위치한 $Na^{+}\;-K^{+}$ 펌프에 의한 능동수송과정(能動輸送過程)이다. 3. ${\alpha}$ 및 ${\beta}$형(形) CA-rich cell은 $Na^+$ 수송(輸送)에 관여하지 않으며, ${\alpha}$형(形)의 CA-cell은 정단세포막(頂端細胞膜)의 proton펌프를 이용하여 proton 분필(分泌)에 관여한다. 또한 ${\beta}$형(形)의 CA-cell는 정단세포막(頂端細胞膜)을 통한 $HCO_{3}^-$ 분필수송(分泌輸送)의 기능을 가지고 있다. 4. 동결절단법(凍結切斷法)의 적용하에 세포막표면(細胞膜表面)의 특성(特性)을 관찰한 바, ${\alpha}$형(形)의 CA-cell의 정단세포막(頂端細胞膜)은 proton펌프를 함유하는 것으로 보이는 intramembrane particle이 다수 관찰되고 있으며, ${\beta}$형(形) CA-cell은 기저세포막(基底細胞膜)에서 이와같은 intramembrane particle이 나타나고 있다. 5. 상술(上述)한 두 type의 CA-cell에서 수송특성(輸送特性)의 차이는 proton 및 $HCO_{3}^-$ 분필수송(分泌輸送)이 서로 반대의 방향으로 일어나는 것으로 사료된다.

• Clinical and Experimental Pediatrics
• /
• 제62권10호
• /
• pp.400-404
• /
• 2019

Background: An increase in the numbers of patients with gastrointestinal symptoms has recently been observed. Purpose: To investigate the effects of proton pump inhibitor (PPI) therapy on intestinal inflammation in children and adolescents as confirmed by clinical manifestations and objectively assessed by fecal calprotectin (FC) level measurement. Methods: Consecutive children (aged 3-18 years) who presented with gastrointestinal symptoms and were treated with or without PPI for at least 1 month were enrolled. Patients were divided into PPI and non-PPI groups. The PPI group was further subdivided by treatment duration and type of PPI used. Stool samples were collected for FC evaluation at baseline and after treatment and clinical data and FC levels were compared between the groups. Results: Fifty-one patients (15 boys, 36 girls) were enrolled in the study. The PPI group included 37 patients, while the non-PPI group included 14 patients. Clinical symptoms were not significantly different. FC levels and laboratory results, including C-reactive protein levels, white blood cell count, and absolute neutrophil count, were not statistically different before versus after PPI treatment. After treatment, FC levels decreased to 8.1 mg/kg (-575.4 to 340.3 mg/kg) in the PPI group and increased to 5.6 mg/kg (-460.0 to 186.9 mg/kg) in the non-PPI group compared to those before treatment (P=0.841). The number of patients with increased FC levels was not significantly different between the 2 groups (48.6% vs. 64.3%, P=0.363), similar to that observed in patients with an FC level > 50 mg/kg (24.3% and 7.1%, P=0.250). PPI therapy type and duration did not affect the FC levels (P=0.811 and P=0.502, respectively). Conclusion: Although we aimed to confirm the evidence of intestinal inflammation due to PPI use in children and adolescents through clinical symptoms and FC measurement, no significant changes were observed.

• 한국식품위생안전성학회지
• /
• 제31권4호
• /
• pp.286-293
• /
• 2016

본 연구에서는 ursolic acid의 위의 보호효과를 위한 실험을 실시하였다. 위장 질병에 대한 ursolic acid의 효과를 확인하기 위해서 급성, 만성위염은 각각의 HCl ethanol과 indomethacin에 의해 유도된 위염 동물 모델을 사용하여 관찰하였다. 대표적인 공격인자인 위산에 관해서는 PPI activity를 통해서 확인하였고, 위의 손상에 대한 보호인자에 관해서는, $PGE_2$를 정량적으로 분석하였다. 항균활성 실험은 만성위염, 위궤양, 위암에 원인인자로 잘 알려진 H. pylori로 실험하였다. AGS cell를 이용하여 DAPI 염색, Flow cytometry assay를 통하여 ursolic acid가 위암세포의 apoptosis에 관여하는지를 확인하였다. 그 결과 ursolic acid는 HCl ethanol과 indomethacin에 의해 유도된 급성, 만성에 대한 위손상을 억제하였다. Ursolic acid는 위산분비의 마지막 단계인 위염분비효소인 proton pump를 억제시킴으로써 산의 분비를 억제하였다. 그리고 ursolic acid는 위 점막의 보호인자인 $PGE_2$의 농도가 증가함으로써 위 점막 보호 효과를 확인하였다. 또한 ursolic acid는 공격인자인 H. pylori colonization을 억제하였다. DAPI를 이용한 핵 염색에서, 대조군과는 달리, 핵 형상의 변형과 함께 수축 된 세포 또는 염색질의 응축현상이 관찰되었다. Flow cytometry assay에서 ursolic acid에 의해 apoptosis가 증가하는 것을 확인 하였다. 이를 통하여 ursolic acid는 위 손상에 대한 방어 효과가 있음을 확인할 수 있었다.

• Journal of Gastric Cancer
• /
• 제17권2호
• /
• pp.120-131
• /
• 2017

Purpose: Tumor bleeding is a major complication in inoperable gastric cancer. The study aim was to investigate the effects of proton pump inhibitor (PPI) treatment for the prevention of gastric tumor bleeding. Materials and Methods: This study was a prospective double-blind, randomized, placebo-controlled trial. Patients with inoperable gastric cancer were randomly assigned to receive oral lansoprazole (30 mg) or placebo daily. The primary endpoint was the occurrence of tumor bleeding, and the secondary endpoints were transfusion requirement and overall survival (OS). Results: This study initially planned to enroll 394 patients, but prematurely ended due to low recruitment rate. Overall, 127 patients were included in the analyses: 64 in the lansoprazole group and 63 in the placebo group. During the median follow-up of 6.4 months, tumor bleeding rates were 7.8% and 9.5%, in the lansoprazole and placebo groups, respectively, with the cumulative bleeding incidence not statistically different between the groups (P=0.515, Gray's test). However, during the initial 4 months, 4 placebo-treated patients developed tumor bleeding, whereas there were no bleeding events in the lansoprazole-treated patients (P=0.041, Gray's test). There was no difference in the proportion of patients who required transfusion between the groups. The OS between the lansoprazole (11.7 months) and the placebo (11.0 months) groups was not statistically different (P=0.610). Study drug-related serious adverse event or bleeding-related death did not occur. Conclusions: Treating patients with inoperable gastric cancer with lansoprazole did not significantly reduce the incidence of tumor bleeding. However, further studies are needed to evaluate whether lansoprazole can prevent tumor bleeding during earlier phases of chemotherapy (ClinicalTrial.gov, identifier No. NCT02150447).

• 동의생리병리학회지
• /
• 제21권6호
• /
• pp.1549-1554
• /
• 2007

To verify the effects of JAUN-1, which is a water-extracted herbal mixture, on gastroenteric disorders induced by 0.1 percent of iodoacetamide (IA) in rats. We divided four groups, $Na{\"{\i}}ve$ + Distilled Water (DW), 0.1% IA + DW, 0.1% IA + Proton pump inhibitor (Lansoprazole, 5 mg/kg) and 0.1% IA + Herbal mixture (JAUN-1, 50mg/kg) and performed following experimental methods to confirm its advantageous effects against ulcerogenic stomach in rats induced by 0.1% IA; cell cytotoxicity, analysis of lesions score, Hematoxylin & Eosin (H&E) stain, RT-PCR for ${\beta}-actin$, COX-1 and COX-2 and evaluation of intestinal prokinetic activity. No cytotoxicity was elucidated at the concentration of 1, 5, 10, 50, 100, $500\;{\mu}g/ml$ and 1mg/ml JAUN-1 through MTT Assay using by human stomach epithelial AGS cells, respectively. In addition, the JAUN-1 treated group and the lansoprazole treated group significantly decreased in lesions score compared to the DW treated group in the gastritis induced rat model, and results of immunohistochemistry by H&E staining showed that histological recovery in Proton Pump Inhibitor (PPI) and JAUN-1 treated groups rather than the DW administrated group. Another outcome was that ${\beta}-actin$ relative COX-2 expression level was significantly promoted in the DW treated group while ${\beta}-actin$ relative COX-1 expression level was no meaningful change in this rat model. Finally, intestinal prokinetic activity was recovered from low level of prokinetic activity due to 0.1% IA induced gastritis to the similar level of Normal group. These results suggested that JAUN-1 may have beneficial effects against 0.1% IA-induced gastritis rat model through decreasing lesions score, histological recovery, ${\beta}-actin$ relative COX-1, 2 expression level and prokinetic activity.

• Pediatric Gastroenterology, Hepatology & Nutrition
• /
• 제22권6호
• /
• pp.511-517
• /
• 2019

Purpose: On the basis of evidence, we aimed to reevaluate the necessity of the empirical proton pump inhibitor (PPI) trial for children with suspected gastroesophageal reflux disease (GERD). Methods: We analyzed the frequency of GERD in 85 school-age children with gastroesophageal reflux (GER) symptoms, who received 24-hour esophageal pH monitoring and/or upper endoscopy. According to the reflux index (RI), the children were classified into normal (RI <5%), intermediate (5%${\leq}$ RI <10%), or abnormal (RI ${\geq}$10%) groups. Results: Fifty six were female and 29 were male. Their mean age was $12.6{\pm}0.5$ (${\pm}$standard deviation) years (range: 6.8-18.6). The RI analysis showed that the normal group included 76 patients (89.4%), the intermediate group included 6 patients (7.1%), and the abnormal group included 3 patients (3.5%). The DeMeester score was $5.93{\pm}4.65$, $14.68{\pm}7.86$ and $40.37{\pm}12.96$ for the normal, intermediate and abnormal group, respectively (p=0.001). The longest reflux time was $5.56{\pm}6.00$ minutes, $9.53{\pm}7.84$ minutes, and $19.46{\pm}8.35$ minutes in the normal, intermediate, and abnormal group, respectively (p=0.031). Endoscopic findings showed reflux esophagitis in 7 patients. On the basis of the Los Angeles Classification of Esophagitis, 5 of these patients were included in group A, 1 patient, in group B and 1 patient, in group C. Conclusion: The incidence of GERD was very low in school-age children with GER symptoms. Therefore, injudicious diagnostic PPI trials would be postponed until the actual prevalence of GERD is verified in future prospective studies.

• 대한후두음성언어의학회지
• /
• 제32권3호
• /
• pp.135-141
• /
• 2021

Background and Objectives Vocal process granulomas (VPGs) are benign lesions of the larynx, typically contact granulomas (CG) and intubation granulomas (IG). The two diseases are known to have different clinical manifestations despite having the same pathological features. The purpose of this study was to analyze the treatment results for CG and IG and to obtain clinical information. Materials and Method We retrospectively reviewed the medical records of patients diagnosed with VPG between January 2015 and December 2018. The patient's age, sex, medical history, lesion size, lesion type, reflux finding score, response to treatment, duration of treatment, and follow-up period were compared. Results In total, 32 patients were included in the study, of which 18 were CG and 14 were IG. In the CG group, males were dominant (n=15, 83.3%), whereas in the IG group, females were dominant (n=11, 78.6%) (p=0.0009). The response to medical treatment using proton pump inhibitor and steroid inhaler was better in the IG group (11/14, 78.6%) than in the CG group (7/18, 38.9%) (p=0.036). Of the 14 patients who did not respond to medical treatment, 5 received botulium toxin injections, and all 5 had complete remission. The duration of medical treatment was significantly longer in the IG group (p=0.0029). Conclusion IG was more common in female, and CG was more dominant in male. IG had better response to medical treatment using proton pump inhibitor and steroid inhaler than CG.

• 한국정보처리학회:학술대회논문집
• /
• 한국정보처리학회 2006년도 춘계학술발표대회
• /
• pp.399-402
• /
• 2006

한국 원자력 연구소는 PEFP(Proton Enginnering Frontier Poject)라고 하는 프로젝트를 수행 중이며, PEFP는 고에너지 양성자 가속기에 대한 프로젝트이다. 양성자 가속기에 대한 제어 시스템은 안정적인 운전 제어를 위해서 장치의 상태를 주기적으로 모니터링 할 뿐만 아니라 장치상태를 저장하여 일정시간 후에 확인이 요구되면 저장된 데이터를 이용하여 이전 정보를 추적할 수 있어야한다. 따라서 양성자 가속기 제어시스템에서는 실시간으로 들어오는 진공 데이터 정보를 저장 및 저장된 데이터를 열람이 가능한 저장 시스템으로 구성하였다. 저장된 데이터들은 RFQ(Radio Frequency Quadrupole) Cryopump, Turbo Pump, Press Gauge, Gate Valve, Compressor와 DTL(Drift Tube Linac) Multi-Gauge, Turbo Pump등의 진공도 및 제어변수 등이 있다. 이들 각각의 진공장치로부터 전달되는 진공 데이터들을 저장하기 위해 EPICS Extension toolset중에서 저장하는 기능을 가진 Channel Archiver를 양성자 가속기 제어 시스템에 추가하였다